Medicare Will Not Fully Cover Aduhelm, the Controversial—and Costly—Alzheimer’s Disease Drug

Medicare said Tuesday it will limit coverage of a $28,000-a-year Alzheimer’s drug whose benefits have been widely questioned, a major development in the nation’s tug-of-war over the fair value of new medicines that offer tantalizing possibilities but come with prohibitive prices.

The initial determination from the Centers for Medicare and Medicaid Services means that patients taking Biogen’s Aduhelm medication will have to be part of research efforts to assess the drug’s effectiveness in slowing the progression of dementia. Medicare’s national coverage determination would become final this spring, following a public comment period and further evaluation by the agency.

The drug has sparked controversy since its approval by the Food and Drug Administration last June, which came against the recommendation of the agency’s outside advisers.

Aduhelm’s initial launch price of $56,000 a year led to an increase of nearly $22 in Medicare’s monthly “Part B” premium for outpatient care, the largest ever in dollar terms but not percentage-wise. Medicare attributed about half of this year’s increase to contingency planning for Aduhelm.

Faced with skepticism over its medication, Biogen recently slashed the price to $28,200, but Medicare enrollees were already on the hook for the $170.10 premium. Health and Human Services Secretary Xavier Becerra has directed Medicare to reassess the premium increase.

Contact us at letters@time.com.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Red Tape Driving Start-ups out of Korea thumbnail

Red Tape Driving Start-ups out of Korea

One in four start-ups in Korea is considering relocating overseas due to red tape here, a poll suggests. The Korea International Trade Association said Sunday that a poll of 256 start-up companies showed that 25.4 percent or 65 are considering moving overseas.Seventeen of them ticked they were "seriously considering" it. Some 113 or 44.1 percent of
Read More
Indian court acquits bishop of charge of raping nun thumbnail

Indian court acquits bishop of charge of raping nun

NEW DELHI (AP) — An Indian court on Friday acquitted a Roman Catholic bishop of charges of raping a nun in her rural convent, a case that became a major issue amid allegations of sexual harassment in the church. Sessions Judge G. Gopakumar in a brief order said the bishop was not guilty of charges…
Read More
Indigenous tourism officials now predicting quicker recovery from pandemic thumbnail

Indigenous tourism officials now predicting quicker recovery from pandemic

By By Sam Laskaris, Local Journalism Initiative Reporter, Windspeaker.comWindspeaker.comWed., Jan. 12, 2022timer3 min. readA lengthy recovery from the pandemic, lasting perhaps as long as a decade, is no longer being predicted for the Indigenous tourism industry in Canada. Keith Henry, the president and CEO of the Indigenous Tourism Association of Canada (ITAC), had said this…
Read More
Среща на високо равнище: Румен Радев заминава за Варшава thumbnail

Среща на високо равнище: Румен Радев заминава за Варшава

Президентът Румен Радев ще бъде на работно посещение във Варшава за участие в срещата на високо равнище във формат Б9. Румен Радев: Към момента няма пряка военна заплаха за България, операцията на Русия е недопустима В рамките на международния форум участват България, Естония, Латвия, Литва, Румъния, Словакия, Унгария, Чехия и Полша. Премиерът Кирил Петков е…
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?

Total
0
Share